Swayam Prakash Srivastava Selected Research

Ro 41-0960

11/2017

Deficiency in catechol-o-methyltransferase is linked to a disruption of glucose homeostasis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Swayam Prakash Srivastava Research Topics

Disease

15	Fibrosis (Cirrhosis) 05/2021 - 01/2013
9	Diabetic Nephropathies (Diabetic Nephropathy) 06/2021 - 01/2012
4	Diabetes Mellitus 01/2021 - 12/2015
3	Hyperglycemia 01/2020 - 01/2014
3	Kidney Diseases (Kidney Disease) 01/2020 - 01/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 01/2020
2	Pathologic Processes 01/2019 - 01/2013
2	Body Weight (Weight, Body) 05/2013 - 03/2012
1	Tuberculosis (Tuberculoses) 10/2021
1	Infections 07/2021
1	COVID-19 07/2021
1	Disease Resistance 05/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Glucose Intolerance 11/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Insulin Resistance 11/2014
1	Obesity 11/2014
1	Chronic Renal Insufficiency 01/2014
1	Carcinogenesis 01/2013

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2013
6	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2012
5	goralatideIBA 12/2020 - 01/2014
4	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2021 - 01/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2015
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 01/2012
3	Insulin (Novolin)FDA Link 01/2020 - 05/2013
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2014
2	Sirtuin 3IBA 05/2021 - 01/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020 - 01/2020
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2018 - 11/2017
2	Pharmaceutical PreparationsIBA 01/2016 - 01/2013
2	LinagliptinIBA 09/2015 - 06/2014
2	LipidsIBA 11/2014 - 01/2014
2	Blood Glucose (Blood Sugar)IBA 06/2014 - 05/2013
1	Topoisomerase II InhibitorsIBA 10/2021
1	AMP-Activated Protein KinasesIBA 07/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CollagenIBA 01/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2020
1	cadherin 5IBA 12/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2020
1	SirtuinsIBA 01/2020
1	CytokinesIBA 01/2019
1	ChemokinesIBA 01/2019
1	Mercaptoethanol (2 Mercaptoethanol)IBA 11/2017
1	Ro 41-0960IBA 11/2017
1	imidaprilIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	PhytochemicalsIBA 12/2015
1	IntegrinsIBA 09/2015
1	Cystatin CIBA 09/2015
1	Tyrosine (L-Tyrosine)FDA Link 11/2014
1	Protein Kinase CIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2014
1	Plasminogen Activator Inhibitor 1IBA 01/2014
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2014
1	Biological ProductsIBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2013
1	Drug Therapy (Chemotherapy) 07/2021
1	Oral Administration 01/2016